Tubarial gland sparing for oropharyngeal cancer: Feasibility with intensity modulated proton therapy & intensity modulated radiation therapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40194703.
- Also identified by DOI 10.1016/j.radonc.2025.110882.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The feasibility of sparing tubarial glands in oropharyngeal radiotherapy was assessed using IMPT and IMRT. Tubarial gland absolute mean dose differences of up to 18 Gy were observed between clinical and re-optimized plans without compromising target coverage. IMPT plans met tubarial gland mean dose constraints more often than IMRT plans.
Medical subject headings
- Oropharyngeal Neoplasms
- Radiotherapy, Intensity-Modulated
- Proton Therapy
- Organ Sparing Treatments